CTAK Surgery for Keratoconus

(CTAK Trial)

This trial aims to determine how well CTAK surgery improves vision and daily life for individuals with corneal ectasia or keratoconus, conditions where the cornea thins and bulges. Participants will complete questionnaires before and after surgery to help researchers assess the benefits. Ideal candidates for this trial have corneal ectasia or keratoconus without excessively thin corneas or significant scarring. As a Phase 4 trial, this research focuses on understanding how the already FDA-approved and effective treatment benefits a broader range of patients.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that CTAK surgery for keratoconus is generally well-tolerated. In one study with over 150 successful cases, the surgery proved to be safe and consistent. Another report highlights that by preserving most of the original cornea, CTAK reduces the risk of graft rejection compared to full-thickness transplants, leading to fewer complications. Recovery is typically quicker than with traditional corneal transplants because the procedure is less invasive, aiding faster healing. Overall, CTAK appears to be a safe option for treating keratoconus, with many patients experiencing improved vision.¹²³⁴⁵

Unlike the traditional treatments for keratoconus, which usually include rigid contact lenses or corneal transplants, CTAK Surgery offers a surgical option that could provide more lasting results. Researchers are excited about this approach because it directly addresses the structural issues of the cornea, potentially halting disease progression more effectively. Additionally, the procedure could improve vision quality and reduce the need for ongoing corrective lenses, making it a promising alternative to current methods.

Studies have shown that CTAK surgery can improve vision for people with keratoconus, a condition where the cornea becomes thin and bulges into a cone shape. One study found that 96% of treated eyes showed better vision, with an improvement of 2 to 6 lines on an eye chart. Another report indicated that all patients experienced better distance vision without glasses after the procedure. The CTAK technique also flattens the cornea and corrects vision problems, leading to clearer sight. Most patients notice these improvements quickly, often within a week. Participants in this trial will complete preoperative and postoperative questionnaires to assess patient-reported outcomes after CTAK surgery.¹³⁶⁷⁸